Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Svettmottagningen Hidroskliniken is a leading Nordic medical clinic specializing in the research and treatment of hyperhidrosis (excessive sweating). Founded by Dr. Carl Swartling, a pioneer in the field, the clinic utilizes the proprietary Swartling Method (Swartlingmetoden) to provide highly effective treatments for all areas of the body, including hands, feet, armpits, face, and full-body sweating. The primary therapeutic modality employed is the intradermal injection of botulinum toxin products such as Botox, Dysport, Xeomin, and NeuroBloc, which temporarily block nerve signals to the sweat glands. With over 25 years of clinical experience and a strong foundation in scientific research, the clinic operates multiple locations across Sweden, including Stockholm, Gothenburg, Malmö, and Uppsala. Through its academic collaborations and ongoing clinical studies, Svettmottagningen Hidroskliniken functions as a center of excellence, achieving a patient satisfaction rate exceeding 90%.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Svettmottagningen Hidroskliniken.